Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1CNS 1

Conditions

Glioblastoma 8Brain Neoplasms 8Breast Neoplasms 4Urinary Bladder Neoplasms 3Thyroid Neoplasms 3Ovarian Neoplasms 3Neuroendocrine Tumors 3Neoplasm Metastasis 3Glioma 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Stomach Neoplasms 2Spinal Cord Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Paraganglioma 2Pancreatic Neoplasms 2Neoplasms 2Meningioma 2Lung Neoplasms 2Gliosarcoma 2Carcinoma, Transitional Cell 2Astrocytoma 2Adrenal Gland Neoplasms 2Vaginal Neoplasms 1

Interventions

pirfenidone 1Vinblastine 1Pemetrexed 1Oxycodone 1Morphine 1Methotrexate 1Methadone 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Fentanyl 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Fluorodeoxyglucose F18 × CNS × Clear all
NCT00060008 2014-04-04

Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma

Children's Hospital of Philadelphia

Phase NA Terminated
18 enrolled 4 charts
CNSOther neoplasm

Neurofibromatosis 1, Precancerous Conditions, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡